nodes	percent_of_prediction	percent_of_DWPC	metapath
Solifenacin—multiple sclerosis—Amitriptyline—migraine	0.317	0.608	CpDpCtD
Solifenacin—multiple sclerosis—Gabapentin—migraine	0.204	0.392	CpDpCtD
Solifenacin—CHRM4—Amitriptyline—migraine	0.0765	0.239	CbGbCtD
Solifenacin—CHRM5—Amitriptyline—migraine	0.0748	0.233	CbGbCtD
Solifenacin—CHRM3—Amitriptyline—migraine	0.0478	0.149	CbGbCtD
Solifenacin—CHRM1—Amitriptyline—migraine	0.0416	0.13	CbGbCtD
Solifenacin—CHRM2—Amitriptyline—migraine	0.0383	0.12	CbGbCtD
Solifenacin—CYP3A4—Propranolol—migraine	0.0103	0.0321	CbGbCtD
Solifenacin—CYP3A4—Amitriptyline—migraine	0.00889	0.0277	CbGbCtD
Solifenacin—CYP3A4—Valproic Acid—migraine	0.0081	0.0253	CbGbCtD
Solifenacin—CYP3A4—Topiramate—migraine	0.00731	0.0228	CbGbCtD
Solifenacin—CYP3A4—Verapamil—migraine	0.00705	0.022	CbGbCtD
Solifenacin—Benazepril—MTHFR—migraine	0.00136	0.551	CrCbGaD
Solifenacin—Benazepril—ACE—migraine	0.00111	0.449	CrCbGaD
Solifenacin—Urinary tract infection—Valproic Acid—migraine	0.000265	0.00282	CcSEcCtD
Solifenacin—Infection—Propranolol—migraine	0.000265	0.00282	CcSEcCtD
Solifenacin—Nervous system disorder—Propranolol—migraine	0.000261	0.00278	CcSEcCtD
Solifenacin—Urticaria—Amitriptyline—migraine	0.00026	0.00277	CcSEcCtD
Solifenacin—Hypertension—Verapamil—migraine	0.000259	0.00276	CcSEcCtD
Solifenacin—Skin disorder—Propranolol—migraine	0.000259	0.00276	CcSEcCtD
Solifenacin—Muscular weakness—Gabapentin—migraine	0.000258	0.00275	CcSEcCtD
Solifenacin—Hepatobiliary disease—Valproic Acid—migraine	0.000258	0.00274	CcSEcCtD
Solifenacin—Dysuria—Timolol—migraine	0.000254	0.00271	CcSEcCtD
Solifenacin—Influenza—Gabapentin—migraine	0.000253	0.0027	CcSEcCtD
Solifenacin—Dry mouth—Verapamil—migraine	0.00025	0.00266	CcSEcCtD
Solifenacin—Confusional state—Verapamil—migraine	0.000247	0.00263	CcSEcCtD
Solifenacin—Anaphylactic shock—Verapamil—migraine	0.000245	0.00261	CcSEcCtD
Solifenacin—Infection—Verapamil—migraine	0.000243	0.00259	CcSEcCtD
Solifenacin—Hallucination—Valproic Acid—migraine	0.000243	0.00259	CcSEcCtD
Solifenacin—Pharyngitis—Valproic Acid—migraine	0.000243	0.00259	CcSEcCtD
Solifenacin—Depression—Timolol—migraine	0.000242	0.00258	CcSEcCtD
Solifenacin—Urinary tract disorder—Valproic Acid—migraine	0.000242	0.00257	CcSEcCtD
Solifenacin—Oedema peripheral—Valproic Acid—migraine	0.000241	0.00257	CcSEcCtD
Solifenacin—Connective tissue disorder—Valproic Acid—migraine	0.00024	0.00256	CcSEcCtD
Solifenacin—Urethral disorder—Valproic Acid—migraine	0.00024	0.00255	CcSEcCtD
Solifenacin—Tachycardia—Verapamil—migraine	0.000239	0.00255	CcSEcCtD
Solifenacin—Dysuria—Gabapentin—migraine	0.000237	0.00252	CcSEcCtD
Solifenacin—Somnolence—Propranolol—migraine	0.000237	0.00252	CcSEcCtD
Solifenacin—Asthenia—Amitriptyline—migraine	0.000235	0.0025	CcSEcCtD
Solifenacin—Dyspepsia—Propranolol—migraine	0.000235	0.0025	CcSEcCtD
Solifenacin—Urinary retention—Topiramate—migraine	0.000234	0.0025	CcSEcCtD
Solifenacin—Decreased appetite—Propranolol—migraine	0.000232	0.00247	CcSEcCtD
Solifenacin—Pruritus—Amitriptyline—migraine	0.000231	0.00247	CcSEcCtD
Solifenacin—Erythema multiforme—Valproic Acid—migraine	0.000231	0.00246	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Propranolol—migraine	0.00023	0.00245	CcSEcCtD
Solifenacin—Fatigue—Propranolol—migraine	0.00023	0.00245	CcSEcCtD
Solifenacin—Eye disorder—Valproic Acid—migraine	0.000229	0.00243	CcSEcCtD
Solifenacin—Constipation—Propranolol—migraine	0.000228	0.00243	CcSEcCtD
Solifenacin—Liver function test abnormal—Topiramate—migraine	0.000228	0.00242	CcSEcCtD
Solifenacin—Infestation NOS—Gabapentin—migraine	0.000226	0.00241	CcSEcCtD
Solifenacin—Infestation—Gabapentin—migraine	0.000226	0.00241	CcSEcCtD
Solifenacin—Depression—Gabapentin—migraine	0.000225	0.0024	CcSEcCtD
Solifenacin—Abdominal pain upper—Topiramate—migraine	0.000225	0.0024	CcSEcCtD
Solifenacin—Renal failure—Gabapentin—migraine	0.000222	0.00236	CcSEcCtD
Solifenacin—Angiopathy—Valproic Acid—migraine	0.000222	0.00236	CcSEcCtD
Solifenacin—Immune system disorder—Valproic Acid—migraine	0.000221	0.00235	CcSEcCtD
Solifenacin—Mediastinal disorder—Valproic Acid—migraine	0.00022	0.00235	CcSEcCtD
Solifenacin—Urinary tract infection—Gabapentin—migraine	0.00022	0.00234	CcSEcCtD
Solifenacin—Somnolence—Verapamil—migraine	0.000218	0.00232	CcSEcCtD
Solifenacin—Gastrointestinal pain—Propranolol—migraine	0.000218	0.00232	CcSEcCtD
Solifenacin—Muscular weakness—Topiramate—migraine	0.000217	0.00232	CcSEcCtD
Solifenacin—Hallucination—Timolol—migraine	0.000217	0.00231	CcSEcCtD
Solifenacin—Dizziness—Amitriptyline—migraine	0.000216	0.0023	CcSEcCtD
Solifenacin—Dyspepsia—Verapamil—migraine	0.000216	0.0023	CcSEcCtD
Solifenacin—Oedema peripheral—Timolol—migraine	0.000214	0.00228	CcSEcCtD
Solifenacin—Mental disorder—Valproic Acid—migraine	0.000214	0.00228	CcSEcCtD
Solifenacin—Connective tissue disorder—Timolol—migraine	0.000214	0.00228	CcSEcCtD
Solifenacin—Hepatobiliary disease—Gabapentin—migraine	0.000214	0.00227	CcSEcCtD
Solifenacin—Malnutrition—Valproic Acid—migraine	0.000213	0.00227	CcSEcCtD
Solifenacin—Urticaria—Propranolol—migraine	0.000212	0.00225	CcSEcCtD
Solifenacin—Fatigue—Verapamil—migraine	0.000211	0.00225	CcSEcCtD
Solifenacin—Abdominal pain—Propranolol—migraine	0.000211	0.00224	CcSEcCtD
Solifenacin—Constipation—Verapamil—migraine	0.00021	0.00223	CcSEcCtD
Solifenacin—Dysgeusia—Valproic Acid—migraine	0.000208	0.00222	CcSEcCtD
Solifenacin—Vomiting—Amitriptyline—migraine	0.000208	0.00222	CcSEcCtD
Solifenacin—Rash—Amitriptyline—migraine	0.000206	0.0022	CcSEcCtD
Solifenacin—Dermatitis—Amitriptyline—migraine	0.000206	0.00219	CcSEcCtD
Solifenacin—Headache—Amitriptyline—migraine	0.000205	0.00218	CcSEcCtD
Solifenacin—Eye disorder—Timolol—migraine	0.000203	0.00217	CcSEcCtD
Solifenacin—Cardiac disorder—Timolol—migraine	0.000202	0.00215	CcSEcCtD
Solifenacin—Feeling abnormal—Verapamil—migraine	0.000202	0.00215	CcSEcCtD
Solifenacin—Hallucination—Gabapentin—migraine	0.000202	0.00215	CcSEcCtD
Solifenacin—Pharyngitis—Gabapentin—migraine	0.000201	0.00214	CcSEcCtD
Solifenacin—Vision blurred—Valproic Acid—migraine	0.000201	0.00214	CcSEcCtD
Solifenacin—Urinary tract disorder—Gabapentin—migraine	0.0002	0.00213	CcSEcCtD
Solifenacin—Oedema peripheral—Gabapentin—migraine	0.0002	0.00213	CcSEcCtD
Solifenacin—Dysuria—Topiramate—migraine	0.000199	0.00212	CcSEcCtD
Solifenacin—Connective tissue disorder—Gabapentin—migraine	0.000199	0.00212	CcSEcCtD
Solifenacin—Urethral disorder—Gabapentin—migraine	0.000199	0.00212	CcSEcCtD
Solifenacin—Angiopathy—Timolol—migraine	0.000198	0.0021	CcSEcCtD
Solifenacin—Immune system disorder—Timolol—migraine	0.000197	0.00209	CcSEcCtD
Solifenacin—Hypersensitivity—Propranolol—migraine	0.000196	0.00209	CcSEcCtD
Solifenacin—Mediastinal disorder—Timolol—migraine	0.000196	0.00209	CcSEcCtD
Solifenacin—Urticaria—Verapamil—migraine	0.000195	0.00207	CcSEcCtD
Solifenacin—Angioedema—Valproic Acid—migraine	0.000195	0.00207	CcSEcCtD
Solifenacin—Nausea—Amitriptyline—migraine	0.000194	0.00207	CcSEcCtD
Solifenacin—Erythema multiforme—Gabapentin—migraine	0.000192	0.00204	CcSEcCtD
Solifenacin—Asthenia—Propranolol—migraine	0.000191	0.00204	CcSEcCtD
Solifenacin—Mental disorder—Timolol—migraine	0.000191	0.00203	CcSEcCtD
Solifenacin—Infestation NOS—Topiramate—migraine	0.00019	0.00202	CcSEcCtD
Solifenacin—Infestation—Topiramate—migraine	0.00019	0.00202	CcSEcCtD
Solifenacin—Malnutrition—Timolol—migraine	0.00019	0.00202	CcSEcCtD
Solifenacin—Eye disorder—Gabapentin—migraine	0.000189	0.00202	CcSEcCtD
Solifenacin—Depression—Topiramate—migraine	0.000189	0.00202	CcSEcCtD
Solifenacin—Cardiac disorder—Gabapentin—migraine	0.000188	0.002	CcSEcCtD
Solifenacin—Palpitations—Valproic Acid—migraine	0.000188	0.002	CcSEcCtD
Solifenacin—Renal failure—Topiramate—migraine	0.000187	0.00199	CcSEcCtD
Solifenacin—Cough—Valproic Acid—migraine	0.000186	0.00198	CcSEcCtD
Solifenacin—Dysgeusia—Timolol—migraine	0.000186	0.00198	CcSEcCtD
Solifenacin—Urinary tract infection—Topiramate—migraine	0.000185	0.00197	CcSEcCtD
Solifenacin—Hypertension—Valproic Acid—migraine	0.000184	0.00196	CcSEcCtD
Solifenacin—Immune system disorder—Gabapentin—migraine	0.000183	0.00195	CcSEcCtD
Solifenacin—Mediastinal disorder—Gabapentin—migraine	0.000183	0.00195	CcSEcCtD
Solifenacin—Hypersensitivity—Verapamil—migraine	0.000181	0.00192	CcSEcCtD
Solifenacin—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	0.00018	0.00192	CcSEcCtD
Solifenacin—Vision blurred—Timolol—migraine	0.000179	0.0019	CcSEcCtD
Solifenacin—Mental disorder—Gabapentin—migraine	0.000178	0.00189	CcSEcCtD
Solifenacin—Dry mouth—Valproic Acid—migraine	0.000177	0.00189	CcSEcCtD
Solifenacin—Malnutrition—Gabapentin—migraine	0.000176	0.00188	CcSEcCtD
Solifenacin—Dizziness—Propranolol—migraine	0.000176	0.00188	CcSEcCtD
Solifenacin—Asthenia—Verapamil—migraine	0.000176	0.00187	CcSEcCtD
Solifenacin—Confusional state—Valproic Acid—migraine	0.000175	0.00187	CcSEcCtD
Solifenacin—Anaphylactic shock—Valproic Acid—migraine	0.000174	0.00185	CcSEcCtD
Solifenacin—Pruritus—Verapamil—migraine	0.000173	0.00185	CcSEcCtD
Solifenacin—Angioedema—Timolol—migraine	0.000173	0.00184	CcSEcCtD
Solifenacin—Dysgeusia—Gabapentin—migraine	0.000173	0.00184	CcSEcCtD
Solifenacin—Infection—Valproic Acid—migraine	0.000173	0.00184	CcSEcCtD
Solifenacin—Nervous system disorder—Valproic Acid—migraine	0.00017	0.00181	CcSEcCtD
Solifenacin—Hallucination—Topiramate—migraine	0.00017	0.00181	CcSEcCtD
Solifenacin—Tachycardia—Valproic Acid—migraine	0.00017	0.00181	CcSEcCtD
Solifenacin—Vomiting—Propranolol—migraine	0.000169	0.0018	CcSEcCtD
Solifenacin—Pharyngitis—Topiramate—migraine	0.000169	0.0018	CcSEcCtD
Solifenacin—Skin disorder—Valproic Acid—migraine	0.000169	0.0018	CcSEcCtD
Solifenacin—Urinary tract disorder—Topiramate—migraine	0.000168	0.00179	CcSEcCtD
Solifenacin—Oedema peripheral—Topiramate—migraine	0.000168	0.00179	CcSEcCtD
Solifenacin—Rash—Propranolol—migraine	0.000168	0.00179	CcSEcCtD
Solifenacin—Dermatitis—Propranolol—migraine	0.000168	0.00179	CcSEcCtD
Solifenacin—Connective tissue disorder—Topiramate—migraine	0.000168	0.00179	CcSEcCtD
Solifenacin—Palpitations—Timolol—migraine	0.000167	0.00178	CcSEcCtD
Solifenacin—Urethral disorder—Topiramate—migraine	0.000167	0.00178	CcSEcCtD
Solifenacin—Vision blurred—Gabapentin—migraine	0.000166	0.00177	CcSEcCtD
Solifenacin—Cough—Timolol—migraine	0.000165	0.00176	CcSEcCtD
Solifenacin—Hypertension—Timolol—migraine	0.000164	0.00174	CcSEcCtD
Solifenacin—Dizziness—Verapamil—migraine	0.000162	0.00173	CcSEcCtD
Solifenacin—Erythema multiforme—Topiramate—migraine	0.000161	0.00172	CcSEcCtD
Solifenacin—Angioedema—Gabapentin—migraine	0.000161	0.00172	CcSEcCtD
Solifenacin—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	0.00016	0.00171	CcSEcCtD
Solifenacin—Eye disorder—Topiramate—migraine	0.000159	0.0017	CcSEcCtD
Solifenacin—Cardiac disorder—Topiramate—migraine	0.000158	0.00169	CcSEcCtD
Solifenacin—Nausea—Propranolol—migraine	0.000158	0.00169	CcSEcCtD
Solifenacin—Dry mouth—Timolol—migraine	0.000158	0.00168	CcSEcCtD
Solifenacin—Palpitations—Gabapentin—migraine	0.000156	0.00166	CcSEcCtD
Solifenacin—Confusional state—Timolol—migraine	0.000156	0.00166	CcSEcCtD
Solifenacin—Vomiting—Verapamil—migraine	0.000156	0.00166	CcSEcCtD
Solifenacin—Angiopathy—Topiramate—migraine	0.000155	0.00165	CcSEcCtD
Solifenacin—Anaphylactic shock—Timolol—migraine	0.000155	0.00165	CcSEcCtD
Solifenacin—Rash—Verapamil—migraine	0.000155	0.00165	CcSEcCtD
Solifenacin—Somnolence—Valproic Acid—migraine	0.000154	0.00165	CcSEcCtD
Solifenacin—Dermatitis—Verapamil—migraine	0.000154	0.00164	CcSEcCtD
Solifenacin—Immune system disorder—Topiramate—migraine	0.000154	0.00164	CcSEcCtD
Solifenacin—Cough—Gabapentin—migraine	0.000154	0.00164	CcSEcCtD
Solifenacin—Mediastinal disorder—Topiramate—migraine	0.000154	0.00164	CcSEcCtD
Solifenacin—Infection—Timolol—migraine	0.000154	0.00164	CcSEcCtD
Solifenacin—Headache—Verapamil—migraine	0.000154	0.00163	CcSEcCtD
Solifenacin—Dyspepsia—Valproic Acid—migraine	0.000153	0.00163	CcSEcCtD
Solifenacin—Hypertension—Gabapentin—migraine	0.000152	0.00162	CcSEcCtD
Solifenacin—Nervous system disorder—Timolol—migraine	0.000152	0.00162	CcSEcCtD
Solifenacin—Decreased appetite—Valproic Acid—migraine	0.000151	0.00161	CcSEcCtD
Solifenacin—Skin disorder—Timolol—migraine	0.00015	0.0016	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Valproic Acid—migraine	0.00015	0.0016	CcSEcCtD
Solifenacin—Fatigue—Valproic Acid—migraine	0.00015	0.0016	CcSEcCtD
Solifenacin—Mental disorder—Topiramate—migraine	0.000149	0.00159	CcSEcCtD
Solifenacin—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	0.000149	0.00159	CcSEcCtD
Solifenacin—Constipation—Valproic Acid—migraine	0.000149	0.00158	CcSEcCtD
Solifenacin—Malnutrition—Topiramate—migraine	0.000148	0.00158	CcSEcCtD
Solifenacin—Dry mouth—Gabapentin—migraine	0.000147	0.00157	CcSEcCtD
Solifenacin—Nausea—Verapamil—migraine	0.000146	0.00155	CcSEcCtD
Solifenacin—Dysgeusia—Topiramate—migraine	0.000145	0.00155	CcSEcCtD
Solifenacin—Confusional state—Gabapentin—migraine	0.000145	0.00155	CcSEcCtD
Solifenacin—Anaphylactic shock—Gabapentin—migraine	0.000144	0.00153	CcSEcCtD
Solifenacin—Feeling abnormal—Valproic Acid—migraine	0.000143	0.00152	CcSEcCtD
Solifenacin—Infection—Gabapentin—migraine	0.000143	0.00152	CcSEcCtD
Solifenacin—Gastrointestinal pain—Valproic Acid—migraine	0.000142	0.00151	CcSEcCtD
Solifenacin—Nervous system disorder—Gabapentin—migraine	0.000141	0.0015	CcSEcCtD
Solifenacin—Tachycardia—Gabapentin—migraine	0.000141	0.0015	CcSEcCtD
Solifenacin—Vision blurred—Topiramate—migraine	0.00014	0.00149	CcSEcCtD
Solifenacin—Skin disorder—Gabapentin—migraine	0.00014	0.00149	CcSEcCtD
Solifenacin—Urticaria—Valproic Acid—migraine	0.000138	0.00147	CcSEcCtD
Solifenacin—Somnolence—Timolol—migraine	0.000138	0.00146	CcSEcCtD
Solifenacin—Abdominal pain—Valproic Acid—migraine	0.000137	0.00146	CcSEcCtD
Solifenacin—Dyspepsia—Timolol—migraine	0.000136	0.00145	CcSEcCtD
Solifenacin—Decreased appetite—Timolol—migraine	0.000134	0.00143	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Timolol—migraine	0.000134	0.00142	CcSEcCtD
Solifenacin—Fatigue—Timolol—migraine	0.000133	0.00142	CcSEcCtD
Solifenacin—Palpitations—Topiramate—migraine	0.000131	0.0014	CcSEcCtD
Solifenacin—Cough—Topiramate—migraine	0.00013	0.00138	CcSEcCtD
Solifenacin—Hypertension—Topiramate—migraine	0.000128	0.00137	CcSEcCtD
Solifenacin—Somnolence—Gabapentin—migraine	0.000128	0.00136	CcSEcCtD
Solifenacin—Hypersensitivity—Valproic Acid—migraine	0.000128	0.00136	CcSEcCtD
Solifenacin—Feeling abnormal—Timolol—migraine	0.000127	0.00136	CcSEcCtD
Solifenacin—Dyspepsia—Gabapentin—migraine	0.000127	0.00135	CcSEcCtD
Solifenacin—Gastrointestinal pain—Timolol—migraine	0.000126	0.00135	CcSEcCtD
Solifenacin—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	0.000126	0.00134	CcSEcCtD
Solifenacin—Decreased appetite—Gabapentin—migraine	0.000125	0.00133	CcSEcCtD
Solifenacin—Asthenia—Valproic Acid—migraine	0.000125	0.00133	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Gabapentin—migraine	0.000124	0.00132	CcSEcCtD
Solifenacin—Fatigue—Gabapentin—migraine	0.000124	0.00132	CcSEcCtD
Solifenacin—Dry mouth—Topiramate—migraine	0.000124	0.00132	CcSEcCtD
Solifenacin—Constipation—Gabapentin—migraine	0.000123	0.00131	CcSEcCtD
Solifenacin—Pruritus—Valproic Acid—migraine	0.000123	0.00131	CcSEcCtD
Solifenacin—Urticaria—Timolol—migraine	0.000123	0.00131	CcSEcCtD
Solifenacin—Abdominal pain—Timolol—migraine	0.000122	0.0013	CcSEcCtD
Solifenacin—Confusional state—Topiramate—migraine	0.000122	0.0013	CcSEcCtD
Solifenacin—Infection—Topiramate—migraine	0.00012	0.00128	CcSEcCtD
Solifenacin—Nervous system disorder—Topiramate—migraine	0.000119	0.00127	CcSEcCtD
Solifenacin—Feeling abnormal—Gabapentin—migraine	0.000119	0.00126	CcSEcCtD
Solifenacin—Tachycardia—Topiramate—migraine	0.000118	0.00126	CcSEcCtD
Solifenacin—Gastrointestinal pain—Gabapentin—migraine	0.000118	0.00125	CcSEcCtD
Solifenacin—Skin disorder—Topiramate—migraine	0.000118	0.00125	CcSEcCtD
Solifenacin—Dizziness—Valproic Acid—migraine	0.000115	0.00122	CcSEcCtD
Solifenacin—Urticaria—Gabapentin—migraine	0.000114	0.00122	CcSEcCtD
Solifenacin—Hypersensitivity—Timolol—migraine	0.000114	0.00121	CcSEcCtD
Solifenacin—Abdominal pain—Gabapentin—migraine	0.000114	0.00121	CcSEcCtD
Solifenacin—Asthenia—Timolol—migraine	0.000111	0.00118	CcSEcCtD
Solifenacin—Vomiting—Valproic Acid—migraine	0.00011	0.00118	CcSEcCtD
Solifenacin—Rash—Valproic Acid—migraine	0.00011	0.00117	CcSEcCtD
Solifenacin—Dermatitis—Valproic Acid—migraine	0.000109	0.00117	CcSEcCtD
Solifenacin—Pruritus—Timolol—migraine	0.000109	0.00117	CcSEcCtD
Solifenacin—Headache—Valproic Acid—migraine	0.000109	0.00116	CcSEcCtD
Solifenacin—Somnolence—Topiramate—migraine	0.000108	0.00115	CcSEcCtD
Solifenacin—Dyspepsia—Topiramate—migraine	0.000107	0.00114	CcSEcCtD
Solifenacin—Hypersensitivity—Gabapentin—migraine	0.000106	0.00113	CcSEcCtD
Solifenacin—Decreased appetite—Topiramate—migraine	0.000105	0.00112	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Topiramate—migraine	0.000105	0.00111	CcSEcCtD
Solifenacin—Fatigue—Topiramate—migraine	0.000104	0.00111	CcSEcCtD
Solifenacin—Constipation—Topiramate—migraine	0.000104	0.0011	CcSEcCtD
Solifenacin—Asthenia—Gabapentin—migraine	0.000103	0.0011	CcSEcCtD
Solifenacin—Nausea—Valproic Acid—migraine	0.000103	0.0011	CcSEcCtD
Solifenacin—Dizziness—Timolol—migraine	0.000102	0.00109	CcSEcCtD
Solifenacin—Pruritus—Gabapentin—migraine	0.000102	0.00109	CcSEcCtD
Solifenacin—Feeling abnormal—Topiramate—migraine	9.99e-05	0.00106	CcSEcCtD
Solifenacin—Gastrointestinal pain—Topiramate—migraine	9.91e-05	0.00106	CcSEcCtD
Solifenacin—Vomiting—Timolol—migraine	9.83e-05	0.00105	CcSEcCtD
Solifenacin—Rash—Timolol—migraine	9.75e-05	0.00104	CcSEcCtD
Solifenacin—Dermatitis—Timolol—migraine	9.74e-05	0.00104	CcSEcCtD
Solifenacin—Headache—Timolol—migraine	9.69e-05	0.00103	CcSEcCtD
Solifenacin—Urticaria—Topiramate—migraine	9.63e-05	0.00103	CcSEcCtD
Solifenacin—Abdominal pain—Topiramate—migraine	9.58e-05	0.00102	CcSEcCtD
Solifenacin—Dizziness—Gabapentin—migraine	9.53e-05	0.00101	CcSEcCtD
Solifenacin—Nausea—Timolol—migraine	9.19e-05	0.000978	CcSEcCtD
Solifenacin—Vomiting—Gabapentin—migraine	9.16e-05	0.000975	CcSEcCtD
Solifenacin—Rash—Gabapentin—migraine	9.08e-05	0.000967	CcSEcCtD
Solifenacin—Dermatitis—Gabapentin—migraine	9.07e-05	0.000966	CcSEcCtD
Solifenacin—Headache—Gabapentin—migraine	9.02e-05	0.000961	CcSEcCtD
Solifenacin—Hypersensitivity—Topiramate—migraine	8.93e-05	0.000951	CcSEcCtD
Solifenacin—Asthenia—Topiramate—migraine	8.69e-05	0.000926	CcSEcCtD
Solifenacin—Pruritus—Topiramate—migraine	8.57e-05	0.000913	CcSEcCtD
Solifenacin—Nausea—Gabapentin—migraine	8.56e-05	0.000911	CcSEcCtD
Solifenacin—Dizziness—Topiramate—migraine	8.01e-05	0.000853	CcSEcCtD
Solifenacin—Vomiting—Topiramate—migraine	7.71e-05	0.000821	CcSEcCtD
Solifenacin—Rash—Topiramate—migraine	7.64e-05	0.000814	CcSEcCtD
Solifenacin—Dermatitis—Topiramate—migraine	7.63e-05	0.000813	CcSEcCtD
Solifenacin—Headache—Topiramate—migraine	7.59e-05	0.000809	CcSEcCtD
Solifenacin—Nausea—Topiramate—migraine	7.2e-05	0.000767	CcSEcCtD
Solifenacin—CHRM5—GPCR ligand binding—HTR7—migraine	5.95e-05	0.000968	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—RAMP1—migraine	5.92e-05	0.000963	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—CALCRL—migraine	5.92e-05	0.000963	CbGpPWpGaD
Solifenacin—CHRM1—G alpha (q) signalling events—HTR2A—migraine	5.82e-05	0.000946	CbGpPWpGaD
Solifenacin—CHRM3—G alpha (q) signalling events—HTR2A—migraine	5.8e-05	0.000943	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—HTR2B—migraine	5.75e-05	0.000936	CbGpPWpGaD
Solifenacin—CHRM4—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	5.71e-05	0.000929	CbGpPWpGaD
Solifenacin—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	5.5e-05	0.000895	CbGpPWpGaD
Solifenacin—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	5.48e-05	0.000892	CbGpPWpGaD
Solifenacin—CHRM5—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	5.47e-05	0.00089	CbGpPWpGaD
Solifenacin—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	5.43e-05	0.000883	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CALCRL—migraine	5.25e-05	0.000855	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—RAMP1—migraine	5.25e-05	0.000855	CbGpPWpGaD
Solifenacin—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—migraine	5.2e-05	0.000846	CbGpPWpGaD
Solifenacin—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—migraine	5.19e-05	0.000844	CbGpPWpGaD
Solifenacin—CHRM1—GPCR ligand binding—HTR1B—migraine	5.14e-05	0.000837	CbGpPWpGaD
Solifenacin—CHRM3—GPCR ligand binding—HTR1B—migraine	5.13e-05	0.000834	CbGpPWpGaD
Solifenacin—CHRM2—GPCR ligand binding—HTR1B—migraine	5.08e-05	0.000826	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—RAMP1—migraine	5.03e-05	0.000818	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CALCRL—migraine	5.03e-05	0.000818	CbGpPWpGaD
Solifenacin—CHRM1—GPCR ligand binding—HTR1A—migraine	4.95e-05	0.000805	CbGpPWpGaD
Solifenacin—CHRM3—GPCR ligand binding—HTR1A—migraine	4.94e-05	0.000803	CbGpPWpGaD
Solifenacin—CHRM2—GPCR ligand binding—HTR1A—migraine	4.89e-05	0.000795	CbGpPWpGaD
Solifenacin—CHRM1—GPCR ligand binding—NPS—migraine	4.88e-05	0.000793	CbGpPWpGaD
Solifenacin—CHRM1—GPCR ligand binding—TAC1—migraine	4.88e-05	0.000793	CbGpPWpGaD
Solifenacin—CHRM3—GPCR ligand binding—NPS—migraine	4.86e-05	0.000791	CbGpPWpGaD
Solifenacin—CHRM3—GPCR ligand binding—TAC1—migraine	4.86e-05	0.000791	CbGpPWpGaD
Solifenacin—CHRM2—GPCR ligand binding—TAC1—migraine	4.81e-05	0.000783	CbGpPWpGaD
Solifenacin—CHRM2—GPCR ligand binding—NPS—migraine	4.81e-05	0.000783	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—HTR1D—migraine	4.8e-05	0.000781	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—HTR1D—migraine	4.78e-05	0.000778	CbGpPWpGaD
Solifenacin—CHRM1—GPCR ligand binding—HTR2C—migraine	4.78e-05	0.000778	CbGpPWpGaD
Solifenacin—CHRM3—GPCR ligand binding—HTR2C—migraine	4.77e-05	0.000775	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—HTR1D—migraine	4.74e-05	0.00077	CbGpPWpGaD
Solifenacin—CHRM2—GPCR ligand binding—HTR2C—migraine	4.72e-05	0.000768	CbGpPWpGaD
Solifenacin—CHRM1—GPCR ligand binding—EDNRA—migraine	4.65e-05	0.000757	CbGpPWpGaD
Solifenacin—CHRM3—GPCR ligand binding—EDNRA—migraine	4.64e-05	0.000754	CbGpPWpGaD
Solifenacin—CHRM2—GPCR ligand binding—EDNRA—migraine	4.59e-05	0.000747	CbGpPWpGaD
Solifenacin—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	4.5e-05	0.000731	CbGpPWpGaD
Solifenacin—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	4.48e-05	0.000729	CbGpPWpGaD
Solifenacin—CHRM1—GPCR ligand binding—CALCA—migraine	4.48e-05	0.000728	CbGpPWpGaD
Solifenacin—CHRM3—GPCR ligand binding—CALCA—migraine	4.46e-05	0.000726	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—HTR2B—migraine	4.46e-05	0.000726	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—HTR2B—migraine	4.45e-05	0.000723	CbGpPWpGaD
Solifenacin—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	4.44e-05	0.000722	CbGpPWpGaD
Solifenacin—CHRM2—GPCR ligand binding—CALCA—migraine	4.42e-05	0.000719	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—HTR2B—migraine	4.4e-05	0.000716	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—HTR1D—migraine	4.36e-05	0.000709	CbGpPWpGaD
Solifenacin—CHRM4—GPCR ligand binding—HTR2A—migraine	4.35e-05	0.000708	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—HTR1D—migraine	4.34e-05	0.000707	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—HTR1B—migraine	4.31e-05	0.000701	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—HTR1D—migraine	4.3e-05	0.0007	CbGpPWpGaD
Solifenacin—CHRM1—GPCR ligand binding—HTR7—migraine	4.19e-05	0.000681	CbGpPWpGaD
Solifenacin—CHRM3—GPCR ligand binding—HTR7—migraine	4.17e-05	0.000679	CbGpPWpGaD
Solifenacin—CHRM5—GPCR ligand binding—HTR2A—migraine	4.17e-05	0.000678	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—HTR1A—migraine	4.15e-05	0.000675	CbGpPWpGaD
Solifenacin—CHRM2—GPCR ligand binding—HTR7—migraine	4.13e-05	0.000673	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—HTR1B—migraine	4.13e-05	0.000672	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—NPS—migraine	4.09e-05	0.000665	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—TAC1—migraine	4.09e-05	0.000665	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—HTR2B—migraine	4.05e-05	0.000659	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—HTR2B—migraine	4.04e-05	0.000657	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—HTR2C—migraine	4.01e-05	0.000652	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—HTR2B—migraine	4e-05	0.00065	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—HTR1A—migraine	3.97e-05	0.000646	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—HTR1B—migraine	3.91e-05	0.000637	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—TAC1—migraine	3.91e-05	0.000637	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—NPS—migraine	3.91e-05	0.000637	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—EDNRA—migraine	3.9e-05	0.000634	CbGpPWpGaD
Solifenacin—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	3.85e-05	0.000627	CbGpPWpGaD
Solifenacin—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	3.84e-05	0.000625	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—HTR2C—migraine	3.84e-05	0.000624	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—HTR1D—migraine	3.82e-05	0.000621	CbGpPWpGaD
Solifenacin—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	3.8e-05	0.000619	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—HTR1A—migraine	3.77e-05	0.000613	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—CALCA—migraine	3.75e-05	0.000611	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—HTR1B—migraine	3.75e-05	0.00061	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—EDNRA—migraine	3.73e-05	0.000607	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—TAC1—migraine	3.71e-05	0.000604	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—NPS—migraine	3.71e-05	0.000604	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—HTR1D—migraine	3.66e-05	0.000595	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—HTR2C—migraine	3.64e-05	0.000592	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—HTR1A—migraine	3.61e-05	0.000587	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—CALCA—migraine	3.59e-05	0.000585	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—NPS—migraine	3.55e-05	0.000578	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—TAC1—migraine	3.55e-05	0.000578	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—HTR2B—migraine	3.55e-05	0.000577	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CALCRL—migraine	3.54e-05	0.000576	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—RAMP1—migraine	3.54e-05	0.000576	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—EDNRA—migraine	3.54e-05	0.000576	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—RAMP1—migraine	3.53e-05	0.000574	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CALCRL—migraine	3.53e-05	0.000574	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—HTR7—migraine	3.51e-05	0.000571	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—RAMP1—migraine	3.5e-05	0.000569	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CALCRL—migraine	3.5e-05	0.000569	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—HTR2C—migraine	3.48e-05	0.000567	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—CALCA—migraine	3.41e-05	0.000554	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—HTR2B—migraine	3.4e-05	0.000553	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—EDNRA—migraine	3.39e-05	0.000552	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—HTR7—migraine	3.36e-05	0.000547	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—CALCA—migraine	3.26e-05	0.000531	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—CACNA1A—migraine	3.2e-05	0.000521	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—HTR7—migraine	3.19e-05	0.000519	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—LRP1—migraine	3.12e-05	0.000508	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—HTR7—migraine	3.05e-05	0.000497	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—LRP1—migraine	2.99e-05	0.000487	CbGpPWpGaD
Solifenacin—CHRM1—GPCR ligand binding—HTR2A—migraine	2.93e-05	0.000477	CbGpPWpGaD
Solifenacin—CHRM3—GPCR ligand binding—HTR2A—migraine	2.92e-05	0.000476	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—HTR1B—migraine	2.91e-05	0.000473	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—HTR1B—migraine	2.9e-05	0.000471	CbGpPWpGaD
Solifenacin—CHRM2—GPCR ligand binding—HTR2A—migraine	2.9e-05	0.000471	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—HTR1B—migraine	2.87e-05	0.000467	CbGpPWpGaD
Solifenacin—CHRM2—SIDS Susceptibility Pathways—TNF—migraine	2.85e-05	0.000464	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—HTR1A—migraine	2.8e-05	0.000455	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—HTR1A—migraine	2.79e-05	0.000454	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—HTR1A—migraine	2.76e-05	0.000449	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—NPS—migraine	2.76e-05	0.000448	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—TAC1—migraine	2.76e-05	0.000448	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—TAC1—migraine	2.75e-05	0.000447	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—NPS—migraine	2.75e-05	0.000447	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—TAC1—migraine	2.72e-05	0.000443	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—NPS—migraine	2.72e-05	0.000443	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—HTR2C—migraine	2.7e-05	0.00044	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—HTR2C—migraine	2.69e-05	0.000438	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—HTR2C—migraine	2.67e-05	0.000434	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—HTR1B—migraine	2.64e-05	0.000429	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—HTR1B—migraine	2.63e-05	0.000428	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—EDNRA—migraine	2.63e-05	0.000428	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—EDNRA—migraine	2.62e-05	0.000426	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—HTR1B—migraine	2.61e-05	0.000424	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—EDNRA—migraine	2.59e-05	0.000422	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—HTR1D—migraine	2.57e-05	0.000419	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—HTR1D—migraine	2.57e-05	0.000417	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—HTR1A—migraine	2.54e-05	0.000413	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—HTR1D—migraine	2.54e-05	0.000413	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—HTR1A—migraine	2.53e-05	0.000412	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—CALCA—migraine	2.53e-05	0.000412	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—CALCA—migraine	2.52e-05	0.00041	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—HTR1A—migraine	2.51e-05	0.000408	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—TAC1—migraine	2.5e-05	0.000407	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—NPS—migraine	2.5e-05	0.000407	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—CALCA—migraine	2.5e-05	0.000406	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—TAC1—migraine	2.49e-05	0.000406	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—NPS—migraine	2.49e-05	0.000406	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—TAC1—migraine	2.47e-05	0.000402	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—NPS—migraine	2.47e-05	0.000402	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—HTR2A—migraine	2.46e-05	0.0004	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—HTR2C—migraine	2.45e-05	0.000399	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—HTR2C—migraine	2.45e-05	0.000398	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—HTR2C—migraine	2.42e-05	0.000394	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—NOTCH4—migraine	2.4e-05	0.00039	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—HTR2B—migraine	2.39e-05	0.000389	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—EDNRA—migraine	2.39e-05	0.000388	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—HTR2B—migraine	2.38e-05	0.000388	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—EDNRA—migraine	2.38e-05	0.000387	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—HTR7—migraine	2.37e-05	0.000385	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—HTR2B—migraine	2.36e-05	0.000384	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—HTR7—migraine	2.36e-05	0.000384	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—EDNRA—migraine	2.36e-05	0.000383	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—HTR2A—migraine	2.35e-05	0.000383	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—HTR7—migraine	2.34e-05	0.00038	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—HTR1B—migraine	2.31e-05	0.000376	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—CALCA—migraine	2.3e-05	0.000374	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—NOTCH4—migraine	2.3e-05	0.000373	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—CALCA—migraine	2.29e-05	0.000373	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—CALCA—migraine	2.27e-05	0.000369	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—HTR2A—migraine	2.23e-05	0.000363	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—HTR1A—migraine	2.23e-05	0.000362	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—HTR1B—migraine	2.21e-05	0.00036	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—PGR—migraine	2.19e-05	0.000357	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—NPS—migraine	2.19e-05	0.000357	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—TAC1—migraine	2.19e-05	0.000357	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—HTR2C—migraine	2.15e-05	0.00035	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—HTR7—migraine	2.15e-05	0.00035	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—HTR7—migraine	2.14e-05	0.000349	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—HTR2A—migraine	2.14e-05	0.000348	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—HTR1A—migraine	2.13e-05	0.000347	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—HTR7—migraine	2.12e-05	0.000345	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—LRP1—migraine	2.11e-05	0.000343	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—LRP1—migraine	2.1e-05	0.000342	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—NPS—migraine	2.1e-05	0.000342	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—TAC1—migraine	2.1e-05	0.000342	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—PGR—migraine	2.1e-05	0.000342	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—EDNRA—migraine	2.09e-05	0.00034	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—LRP1—migraine	2.08e-05	0.000338	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—HTR2C—migraine	2.06e-05	0.000335	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—NOTCH3—migraine	2.04e-05	0.000332	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CALCA—migraine	2.01e-05	0.000328	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—EDNRA—migraine	2e-05	0.000326	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—NOTCH3—migraine	1.95e-05	0.000318	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CALCA—migraine	1.93e-05	0.000314	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—HTR7—migraine	1.88e-05	0.000306	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—HTR7—migraine	1.8e-05	0.000293	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—HTR2A—migraine	1.66e-05	0.00027	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—HTR2A—migraine	1.65e-05	0.000269	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—HTR2A—migraine	1.64e-05	0.000266	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—TGFBR2—migraine	1.62e-05	0.000264	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—NOTCH4—migraine	1.62e-05	0.000263	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—NOTCH4—migraine	1.61e-05	0.000262	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—NOTCH4—migraine	1.6e-05	0.00026	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—HTR1B—migraine	1.56e-05	0.000254	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—HTR1B—migraine	1.55e-05	0.000253	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—TGFBR2—migraine	1.55e-05	0.000253	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—HTR1B—migraine	1.54e-05	0.00025	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—HTR2A—migraine	1.51e-05	0.000245	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—HTR1A—migraine	1.5e-05	0.000244	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—HTR2A—migraine	1.5e-05	0.000244	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—HTR1A—migraine	1.5e-05	0.000243	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—HTR2A—migraine	1.49e-05	0.000242	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—HTR1A—migraine	1.48e-05	0.000241	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—TAC1—migraine	1.48e-05	0.00024	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—NPS—migraine	1.48e-05	0.00024	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—PGR—migraine	1.48e-05	0.00024	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—TAC1—migraine	1.47e-05	0.00024	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—NPS—migraine	1.47e-05	0.00024	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—PGR—migraine	1.47e-05	0.00024	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—TAC1—migraine	1.46e-05	0.000237	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—PGR—migraine	1.46e-05	0.000237	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—NPS—migraine	1.46e-05	0.000237	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—HTR2C—migraine	1.45e-05	0.000236	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—HTR2C—migraine	1.44e-05	0.000235	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—HTR2C—migraine	1.43e-05	0.000233	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—EDNRA—migraine	1.41e-05	0.000229	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—EDNRA—migraine	1.41e-05	0.000229	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—EDNRA—migraine	1.39e-05	0.000226	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—NOTCH3—migraine	1.37e-05	0.000224	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—NOTCH3—migraine	1.37e-05	0.000223	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CALCA—migraine	1.36e-05	0.000221	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—NOTCH3—migraine	1.36e-05	0.000221	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CALCA—migraine	1.35e-05	0.00022	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CALCA—migraine	1.34e-05	0.000218	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—HTR2A—migraine	1.32e-05	0.000215	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—HTR7—migraine	1.27e-05	0.000207	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—HTR7—migraine	1.27e-05	0.000206	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—HTR2A—migraine	1.26e-05	0.000205	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—HTR7—migraine	1.25e-05	0.000204	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—CACNA1A—migraine	1.25e-05	0.000204	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—ESR1—migraine	1.17e-05	0.00019	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—ESR1—migraine	1.12e-05	0.000182	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—TGFBR2—migraine	1.09e-05	0.000178	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—TGFBR2—migraine	1.09e-05	0.000177	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—TGFBR2—migraine	1.08e-05	0.000176	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—MTHFR—migraine	1.06e-05	0.000172	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—HTR2A—migraine	8.89e-06	0.000145	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—HTR2A—migraine	8.86e-06	0.000144	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—HTR2A—migraine	8.78e-06	0.000143	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—ESR1—migraine	7.89e-06	0.000128	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—ESR1—migraine	7.87e-06	0.000128	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—ESR1—migraine	7.79e-06	0.000127	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—MTHFR—migraine	4.14e-06	6.73e-05	CbGpPWpGaD
